Response to ovulation induction treatments in women with polycystic ovary syndrome as a function of serum anti-Müllerian hormone levels

被引：0
|
作者：
Stylianos Vagios
Caitlin R. Sacha
Karissa C. Hammer
Irene Dimitriadis
Kaitlyn E. James
Charles L. Bormann
Irene Souter
机构：
[1] Massachusetts General Hospital and Harvard Medical School,Massachusetts General Hospital Fertility Center, Department of Obstetrics, Gynecology, and Reproductive Biology, Division of Reproductive Endocrinology and Infertility
[2] Massachusetts General Hospital and Harvard Medical School,Deborah Kelly Center for Outcomes Research, Department of Obstetrics, Gynecology, and Reproductive Biology
来源：
Journal of Assisted Reproduction and Genetics | 2021年 / 38卷
关键词：
PCOS; Ovulation induction; Treatment response; AMH;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1827 / 1833
页数：6
相关论文
共 50 条
  • [41] Ovulation induction in women with polycystic ovary syndrome
    Nader, Shahla
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2007, 3 (06): : 438 - 439
  • [42] Anti-Müllerian Hormone Expression in the Ovarian Follicles and Factors Related to Serum Anti-Müllerian Hormone Concentrations in the Domestic Queens
    Gozer, A.
    Dogruer, G.
    Gokcek, I
    Kutlu, T.
    Bahan, O.
    Yagci, I. Pir
    JOURNAL OF THE HELLENIC VETERINARY MEDICAL SOCIETY, 2024, 75 (01): : 6915 - 6924
  • [43] Ovulation induction in women with polycystic ovary syndrome
    Perales-Puchalt, Alfredo
    Legro, Richard S.
    STEROIDS, 2013, 78 (08) : 767 - 772
  • [44] Ovulation induction in women with polycystic ovary syndrome
    Palomba, Stefano
    Orio, Francesco
    Zullo, Fulvio
    FERTILITY AND STERILITY, 2006, 86 : S26 - S27
  • [45] Ovulation induction in women with polycystic ovary syndrome
    Shahla Nader
    Nature Clinical Practice Endocrinology & Metabolism, 2007, 3 : 438 - 439
  • [46] The effects of orchiopexy on serum anti-Müllerian hormone levels in unilateral cryptorchid infants
    Mehmet Demircan
    Aysehan Akinci
    Murat Mutus
    Pediatric Surgery International, 2006, 22 : 271 - 273
  • [47] What is the optimal threshold of serum Anti-Müllerian hormone (AMH) necessary for IVM treatments?
    Alon Kedem
    Gil M. Yerushalmi
    Ettie Maman
    Rina Hemi
    Mirit Hanochi
    Ariel Hourvitz
    Journal of Assisted Reproduction and Genetics, 2013, 30 : 745 - 751
  • [48] Antimüllerian hormone level predicts ovulation in women with polycystic ovary syndrome treated with clomiphene and metformin
    Komorowski, Allison S.
    Hughes, Lydia
    Sarkar, Prottusha
    Aaby, David A.
    Kumar, Ajay
    Kalra, Bhanu
    Legro, Richard S.
    Boots, Christina E.
    FERTILITY AND STERILITY, 2024, 121 (04) : 660 - 668
  • [49] Validation of an Anti-Müllerian Hormone Cutoff for Polycystic Ovarian Morphology in the Diagnosis of Polycystic Ovary Syndrome in the HARMONIA Study: Protocol for a Prospective, Noninterventional Study
    Piltonen, Terhi
    Allegranza, Deirdre
    Hund, Martin
    Buck, Katharina
    Sillman, Johanna
    Arffman, Riikka K.
    JMIR RESEARCH PROTOCOLS, 2024, 13
  • [50] Persistent Müllerian duct syndrome: A novel mutation in the Anti-Müllerian Hormone gene
    Ayça Altincik
    Fahri Karaca
    Hüseyin Onay
    Hormones, 2017, 16 : 205 - 208
12345